SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $26,000 | +8.3% | 100,000 | 0.0% | 0.00% | – |
Q1 2016 | $24,000 | -31.4% | 100,000 | 0.0% | 0.00% | – |
Q4 2015 | $35,000 | -79.9% | 100,000 | 0.0% | 0.00% | -100.0% |
Q3 2015 | $174,000 | -97.2% | 100,000 | -96.9% | 0.00% | -97.1% |
Q1 2015 | $6,286,000 | +132.0% | 3,240,000 | +260.0% | 0.04% | +84.2% |
Q3 2014 | $2,709,000 | +160.0% | 900,000 | +445.5% | 0.02% | +90.0% |
Q3 2013 | $1,042,000 | – | 164,980 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 30,197,945 | $80,025,000 | 92.06% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 457,458 | $1,212,000 | 0.22% |
Verity Asset Management, Inc. | 82,383 | $218,000 | 0.21% |
STONERIDGE INVESTMENT PARTNERS LLC | 332,238 | $880,000 | 0.12% |
Cutler Capital Management, LLC | 62,500 | $165,000 | 0.07% |
Capital Impact Advisors, LLC | 37,788 | $100,000 | 0.05% |
SECOR Capital Advisors, LP | 35,087 | $93,000 | 0.04% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 50,814 | $134,000 | 0.04% |
BOLTON LP | 37,700 | $100,000 | 0.03% |
BOLTON LP | 37,700 | $100,000 | 0.03% |